Login to Your Account

BIO 2012

Bi-Specific Antibodies Making R&D Headway at Long Last

By Nuala Moran
Staff Writer

Thursday, June 21, 2012

BOSTON – They've been around since the 1990s, but until recently were held back by unpredictability in manufacturing, inability to manufacture at scale, poor stability and a short half-life.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription